William Demant Holding A/S (WDH.CO)

WDH.CO on Copenhagen Stock Exchange

435.70DKK
10:59am EDT
Price Change (% chg)

kr.-2.80 (-0.64%)
Prev Close
kr.438.50
Open
kr.438.50
Day's High
kr.439.90
Day's Low
kr.432.30
Volume
80,911
Avg. Vol
103,926
52-wk High
kr.543.50
52-wk Low
kr.432.30

WDH.CO

Chart for WDH.CO

About

William Demant Holding A/S is a Denmark-based company engaged in healthcare industry. It is the parent company within the William Demant group (the Group). It develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The Group focuses on three business areas: Hearing... (more)

Overall

Beta: 0.31
Market Cap (Mil.): kr.24,846.13
Shares Outstanding (Mil.): 56.66
Dividend: --
Yield (%): --

Financials

  WDH.CO Industry Sector
P/E (TTM): 19.01 32.07 33.47
EPS (TTM): 23.07 -- --
ROI: 23.59 8.58 17.39
ROE: 26.00 12.00 18.25
Search Stocks

UPDATE 2-Danish hearing aid makers disappoint despite continued growth

* GN Store Nord seen ahead of the pack with iPhone device (Adds William Demant results, quotes, background, share prices)

14 Aug 2014

William Demant to launch share buy-back programme

COPENHAGEN, Aug 14 - The world's second-largest hearing aid maker, Denmark's William Demant Holding, reported a fall in first-half operating profit, capped by currency headwinds, but kept its full-year outlook for earnings per share unchanged.

14 Aug 2014

William Demant's H1 lags forecasts, 2014 outlook unchanged

COPENHAGEN, Aug 14 - The world's second-largest hearing aid maker, Denmark's William Demant Holding, reported a fall in first-half operating profit, capped by currency headwinds, but kept its full-year outlook for earnings per share unchanged.

14 Aug 2014

William Demant stands by 2014 outlook after Q1

COPENHAGEN, May 8 - William Demant, the world's second-biggest hearing aids maker, kept its full-year forecast for earnings per share unchanged after reporting first-quarter revenue growth on Thursday.

08 May 2014

FDA approves William Demant hearing aid against tinnitus

COPENHAGEN - William Demant has received approval for its first hearing aid reducing tinnitus from the United States Food and Drug Administration (FDA), the Danish company told Reuters on Thursday.

27 Mar 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Thomson Reuters StreetEvents
$75.00
Provider: GlobalData
$125.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks